MedTrace Logo

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

NCT01741350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2014-02-27

Study results available
· View outcomes & findings →

Summary

To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.

Conditions

  • HIV
  • Opioid Dependence

Interventions

BEHAVIORAL

Community-friendly Health Recovery Program

Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management).

BEHAVIORAL

Time-and-Attention-Matched Control Condition

Four weekly support groups and routine clinical services (i.e., daily methadone and case management).

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • APT Foundation, Inc.

    collaborator OTHER

  • University of Connecticut

    lead OTHER

Principal Investigators

  • Michael C Copenhaver, Ph.D. · University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2011-05-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741350 on ClinicalTrials.gov